Boston Scientific‘s new Blazer Open-Irrigated Catheter has now been used for the first time in the U.S. in a study to evaluate its effectiveness in treating sustained or recurrent Type 1 atrial flutter. The study, titled BLOCk-CTI (Blazer Open-Irrigated Catheter Clinical Trial), is a prospective, randomized trial that will involve up to 240 patients.
"The Blazer Open-Irrigated Catheter combines a new technique for irrigated ablation with the reliability of the proven Blazer platform," said Emile Daoud, M.D., Section Chief, Cardiac Electrophysiology, Ross Heart Hospital at the Ohio State University Medical Center in Columbus, who performed the first U.S. procedure. "The open-irrigated catheter performed well with excellent maneuverability, torque and catheter stability."
The Blazer Open-Irrigated Catheter integrates Total Tip Cooling Technology with the high-performance Blazer® Catheter Platform. Total Tip Cooling Technology is intended to offer consistent cooling of the entire ablation tip electrode throughout radiofrequency energy delivery.
Press release: Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.